Cardio Diagnostics Holdings Inc (CDIO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.02 (-0.49%), Market cap $0.01B, 52-week low–high $0.16 ~ $6.55.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel bioph
Financial statements, price targets, institutional (13F) holdings and related news for Cardio Diagnostics Holdings Inc are updated in real time on BlackAll Trade.
Cardio Diagnostics Holdings Inc trades at $2.02 (-0.49%). Real-time quotes and charts are available on BlackAll Trade.
Cardio Diagnostics Holdings Inc has a market cap of about $0.01B.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disea